Table 6.
Crude and Adjusted Hazard Ratiosa for Death From PH Among the Study Cohort During the Follow‐Up Period
| Cohort All (n=9783) | Crude Hazard Ratio (95% CI) | Adjusted Hazard Ratio (95% CI) |
|---|---|---|
| PH | ||
| Yes | 3.01b (2.67–3.41) | 3.30b (2.92–3.73) |
| No (reference) | 1.000 | 1.000 |
| Age, y | ||
| <50 (reference) | 1.000 | 1.000 |
| 50 to 64 | 4.41b (3.24–5.99) | 3.73b (2.73–5.09) |
| ≥65 | 14.36b (10.99–18.77) | 10.77b (8.17–14.22) |
| Sex | ||
| Male | 1.67b (1.51–1.86) | 1.34b (1.20–1.49) |
| Female (reference) | 1.000 | 1.000 |
| Hypertension | ||
| Yes | 2.54b (2.28–2.82) | 1.40b (1.25–1.56) |
| No (reference) | 1.000 | 1.000 |
| Diabetes mellitus | ||
| Yes | 2.17b (1.94–2.43) | 1.49b (1.32–1.67) |
| No (reference) | 1.000 | 1.000 |
| Hyperlipidemia | ||
| Yes | 1.04 (0.83–1.29) | 0.70b (0.56–0.88) |
| No (reference) | 1.000 | 1.000 |
| CAD | ||
| Yes | 2.11b (1.89–2.36) | 1.14b (1.01–1.28) |
| No (reference) | 1.000 | 1.000 |
CAD indicates coronary artery disease; PH, pulmonary hypertension.
a
Model was adjusted by age, sex, hypertension, diabetes mellitus, hyperlipidemia, and CAD.
b
P<0.05.